Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Lifevantage Corp (LFVN)

LifeVantage revenue falls 22% to $37.1 million; swings to $0.02 loss per share

Negative Impact 4 of 5 earnings

LifeVantage reported fiscal first-quarter results for the three months ended September 30, 2026, with revenue down 22.0% from a year earlier and a net loss of $0.02 per diluted share, compared with net income of $0.17 per share. The decline was driven mainly by lower active accounts and lower sales of the MindBody GLP-1 System, and the company recorded a $1.0 million inventory obsolescence allowance for that product, which pressured margins.

Key points

  • Revenue was $37.1 million, down 22.0% from $47.6 million a year earlier.
  • Net loss was $0.2 million, or $0.02 per diluted share, versus net income of $2.2 million, or $0.17 per share, in the prior year period.
  • Adjusted EPS was $0.05, compared with $0.18 a year earlier; adjusted EBITDA was $1.9 million versus $3.9 million.
  • Cash and cash equivalents were $13.7 million at September 30, 2026, with no debt outstanding; no shares were repurchased, leaving $58.5 million under the $60 million program.

The filing

CompanyLifevantage Corp (LFVN)
Form8-K, current report
Filed with the SECNov 9, 2026, 4:06 PM ET
Accession number0001193125-26-453570

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 6:16 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.